|
 That could represent a shortfall from the company's commitments to
deliver about twice that number of doses to Germany in that quarter,
according to the leaked contract with the EU.
Reuters reported on Tuesday that delivery volumes to the European
Union were expected to be at half the level AstraZeneca had
contracted to supply in the second quarter.
Germany's 16 million doses are in line with this possible shortfall,
because the country was expected to receive about 34 million shots
of the 180 million AstraZeneca agreed to supply the EU in the second
quarter, according to a German health ministry internal document
seen by Reuters and the leaked contract between AstraZeneca and the
EU.
In its statement on Wednesday, the health ministry confirmed the
German forecasts on deliveries contained in the internal document,
which were not previously public.
[to top of second column] |
 According to the document,
dated Feb. 22, Germany is expected to receive
33.8 million doses from AstraZeneca in the third
quarter, beyond the timeline set in the EU
contract, which envisages the completion of
initial deliveries by the end of June.
In total Germany expects from AstraZeneca 56.3
million doses under the EU contract, which is
equal to 18,7% of 300 million doses for the EU.
"In calculating the numbers of doses available
to regions, the Health Ministry has always borne
in mind that the AstraZeneca vaccine was
authorised later than we had expected it to be
in the autumn," the health ministry said.
(Reporting by Riham Alkousaa, editing by Thomas
Escritt and Douglas Busvine; Editing by Giles
Elgood)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
